The outlook of companies tied to the drug's past presents a challenging investment scenario . While the initial boom generated substantial returns , generic copies have significantly eroded sales . Investing in related pharmaceutical firms now requires a thorough assessment of intellectual property protection , evolving healthcare changes, and t… Read More